๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Prevention of bleeds in hemophilia patients with inhibitors: Emerging data and clinical direction

โœ Scribed by Cindy A. Leissinger

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
82 KB
Volume
77
Category
Article
ISSN
0361-8609

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Prospective randomized trial of emergenc
Prospective randomized trial of emergency portacaval shunt and emergency medical therapy in unselected cirrhotic patients with bleeding varices
โœ Dr. Marshall J. Orloff; Dr. Richard H. Bell Jr.; Mark S. Orloff; William G. M. H ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 1023 KB

A prospective randomized trial was conducted in unselected, consecutive patients with bleeding esophageal varices resulting from cirrhosis comparing (1) emergency portacaval shunt performed within 8 hr of initial contact (21 patients) with (2) emergency medical therapy (intravenous vasopressin and e

From Theory to Practice: Applying Curren
From Theory to Practice: Applying Current Clinical Knowledge and Treatment Strategies to the Care of Hemophilia A Patients With Inhibitors
โœ Edward D. Gomperts; Jan Astermark; Alessandro Gringeri; Jerome Teitel ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 666 KB

Two bypassing agents are currently available to circumvent the need for factor FVIII in hemophilia A patients with inhibitors: the activated prothrombin complex FEIBA VH and recombinant activated factor VII (NovoSeven ยฎ ). Both products are highly effective in controlling bleeding in the presence of